Compare MAN & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAN | ENOV |
|---|---|---|
| Founded | 1948 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Fluid Controls |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 1994 | 2008 |
| Metric | MAN | ENOV |
|---|---|---|
| Price | $28.71 | $23.37 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $38.50 | ★ $48.75 |
| AVG Volume (30 Days) | ★ 1.0M | 804.8K |
| Earning Date | 04-16-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.89% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,957,100,000.00 | N/A |
| Revenue This Year | $5.19 | $6.36 |
| Revenue Next Year | $3.43 | $5.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.58 | N/A |
| 52 Week Low | $25.15 | $21.00 |
| 52 Week High | $57.49 | $36.82 |
| Indicator | MAN | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 52.14 | 51.18 |
| Support Level | $28.26 | $21.33 |
| Resistance Level | $29.36 | $23.57 |
| Average True Range (ATR) | 1.31 | 1.12 |
| MACD | 0.39 | -0.01 |
| Stochastic Oscillator | 65.49 | 62.17 |
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that include Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives the maximum of the company's revenue. The company derives maximum geographical revenue from the Southern European region.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.